Sponsor or institution
Clinical trials and research at Curza INC
As of November 12, 2026, Find a Trial lists 6 NIH-funded research projects at this institution, with $5.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6NIH research projects
NIH-funded research (6)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New oral antibiotic for hard-to-treat Gram-negative infections
A program aims to create a new oral antibiotic that can fight multidrug-resistant Gram-negative bacteria.
-
Oral antibiotic for drug-resistant Gram-negative infections
An oral antibiotic being developed to treat people with serious multidrug-resistant Gram-negative bacterial infections.
-
A New Antibiotic for Tough-to-Treat Infections
This project is creating a new type of antibiotic called CZ-02 to fight serious infections caused by bacteria that resist many common medicines.
-
Developing a new antibiotic to fight drug-resistant bacteria
This study is working on new antibiotics to help fight tough bacteria that don't respond to regular treatments, aiming to create safe and effective options for people who need them.
-
Developing new oral antibiotics to treat resistant bacterial infections
This study is working on a new type of antibiotic that can help treat tough infections caused by bacteria that don't respond to many current medicines, aiming to create a safe and effective pill for patients.
-
Developing new antibiotics to fight drug-resistant infections
This study is testing a new antibiotic called CZ-02 that aims to help people with tough infections, like urinary tract infections, caused by bacteria that are hard to treat because they resist current antibiotics.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.